Correlation Between Eli Lilly and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and ProQR Therapeutics BV, you can compare the effects of market volatilities on Eli Lilly and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and ProQR Therapeutics.
Diversification Opportunities for Eli Lilly and ProQR Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eli and ProQR is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Eli Lilly i.e., Eli Lilly and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Eli Lilly and ProQR Therapeutics
Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.52 times more return on investment than ProQR Therapeutics. However, Eli Lilly and is 1.92 times less risky than ProQR Therapeutics. It trades about 0.07 of its potential returns per unit of risk. ProQR Therapeutics BV is currently generating about -0.2 per unit of risk. If you would invest 79,277 in Eli Lilly and on December 26, 2024 and sell it today you would earn a total of 5,958 from holding Eli Lilly and or generate 7.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Eli Lilly and vs. ProQR Therapeutics BV
Performance |
Timeline |
Eli Lilly |
ProQR Therapeutics |
Eli Lilly and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eli Lilly and ProQR Therapeutics
The main advantage of trading using opposite Eli Lilly and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.Eli Lilly vs. Johnson Johnson | Eli Lilly vs. Bristol Myers Squibb | Eli Lilly vs. AbbVie Inc | Eli Lilly vs. Pfizer Inc |
ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |